Insulin-like growth factor 1 and life-history evolution of passerine birds

被引:19
作者
Lodjak, Jaanis [1 ]
Mand, Raivo [1 ]
Magi, Marko [1 ]
机构
[1] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia
关键词
adaptation; comparative study; hormones; insulin-like growth factor 1; phylogeny; trade-off; FACTOR-I; IGF-I; SIGNALING PATHWAYS; OXIDATIVE STRESS; BODY-MASS; EGG SIZE; HORMONE; LONGEVITY; SPAN; RECEPTORS;
D O I
10.1111/1365-2435.12993
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
1. Natural selection has generated a diversity of ways in which vertebrates allocate their resources between fundamental life-history traits. The availability of possible evolutionary trajectories of these traits is limited by various genetic, physiological and phylogenetic constraints. This causes trade-offs due to shared resource pools for, or genetic linkage of, competing traits. The majority of these trade-offs are mediated by hormones and create the variability in phenotypes that can be -observed in nature. 2. Insulin-like growth factor 1 (IGF-1) is an evolutionarily conserved peptide, which has been shown to be essential in the regulation of body size, the pattern of reproductive investment and life span across a broad taxonomic range of model species in laboratory and domesticated conditions. However, studies addressing corresponding evolutionary hypotheses on a broader scale and in free-living vertebrates are very rare. 3. In this phylogenetic comparative study on free-living passerines (Passeriformes), we explore the way in which plasma IGF-1 levels underlie the evolution of body size and demographic fitness correlates (clutch size, egg weight, life span). 4. We showed firstly that IGF-1 levels were positively associated with the body size of passerines, although smaller birds had larger IGF-1-mediated investment into building up their body faster. IGF-1 levels were negatively associated with life span of passerines, and more so in birds with smaller body weight. Finally, IGF-1 levels were negatively associated with clutch size in heavier species, and positively associated with egg weight in species with higher body weight and longer duration of parental care. The pattern was opposite in species with smaller body weight and shorter duration of parental care. 5. The described evolutionary framework indicates that variation in IGF-1 levels can be regarded as an important mechanism that may underlie life-history evolution in passerines. IGF-1 could act as a physiological link mediating the inter-regulatory growth-reproduction-lifespan "life-history triangle" on the pace-of-life continuum. Interestingly, body weight and investment into parental care have likely imposed a constraining effect on the IGF-1-mediated co-evolution of demographic fitness traits, such as life span or reproductive investment. This has limited the availability of adaptive pathways via which those traits could evolve as passerines diversified.
引用
收藏
页码:313 / 323
页数:11
相关论文
共 50 条
  • [21] Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancer
    Li, H.
    Zhao, M.
    Wang, Q.
    Liu, L.
    Qi, Y. N.
    Li, J. Y.
    CURRENT ONCOLOGY, 2016, 23 (01) : E17 - E23
  • [22] Maternal Concentrations of Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 1 During Pregnancy and Birth Weight of Offspring
    Asvold, Bjorn Olav
    Eskild, Anne
    Jenum, Pal A.
    Vatten, Lars J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (02) : 129 - 135
  • [23] Does the interaction between glucocorticoids and insulin-like growth factor 1 predict nestling fitness in a wild passerine?
    Lodjak, Jaanis
    Tilgar, Vallo
    Maegi, Marko
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2016, 225 : 149 - 154
  • [24] Role of the Growth Hormone/Insulin-Like Growth Factor 1 Axis in Neurogenesis
    Aberg, N. David
    PEDIATRIC NEUROENDOCRINOLOGY, 2010, 17 : 63 - 76
  • [25] Insulin-Like Growth Factor Pathway and the Thyroid
    Smith, Terry J.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [26] Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness
    Ahasic, Amy M.
    Tejera, Paula
    Wei, Yongyue
    Su, Li
    Mantzoros, Christos S.
    Bajwa, Ednan K.
    Thompson, B. Taylor
    Christiani, David C.
    CRITICAL CARE MEDICINE, 2015, 43 (12) : 2651 - 2659
  • [27] The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt
    Raslan, Hala M.
    Elhosary, Yasser
    Ezzat, Wafaa M.
    Rasheed, Enas Abdel
    Rasheed, Maha A.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2010, 104 (06) : 429 - 432
  • [28] Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions
    Rubinek, T.
    Modan-Moses, D.
    KLOTHO, 2016, 101 : 85 - 118
  • [29] Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin
    Watanabe, Shin
    Tamura, Toshihiro
    Ono, Koh
    Horiuchi, Hisanori
    Kimura, Takeshi
    Kita, Toru
    Furukawa, Yutaka
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (11) : 1214 - 1222
  • [30] Tetrahydroxystilbene glucoside extends mouse life span via upregulating neural klotho and downregulating neural insulin or insulin-like growth factor 1
    Zhou, Xuanxuan
    Yang, Qian
    Xie, Yanhua
    Sun, Jiyuan
    Hu, Jing
    Qiu, Pengcheng
    Cao, Wei
    Wang, Siwang
    NEUROBIOLOGY OF AGING, 2015, 36 (03) : 1462 - 1470